TytoCare Closes $11M Series B Funding

tytoTytoCare Ltd., a Netanya, Israel-based company developing handheld devices and telehealth platform enabling patients to perform home medical examinations and consult with a remote clinician, closed an $11m Series B funding.

The round was led by Cambia Health Solutions with participation from OrbiMed Advisors, Walgreens, Fosun Pharma and LionBird.

The company intends to use the funds to expedite growth in the U.S., attain FDA approval and execute commercial launch.

Led by Dedi Gilad, founder and CEO, TytoCare provides a device that allows patients to perform a variety of examinations as part of a telehealth visit, all from the comfort of their own home. The accompanying cloud platform provides secured communication, data repository, analytics and data sharing between patients, clinicians and healthcare organizations.



Join the discussion